{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T06:58:58Z","timestamp":1780469938843,"version":"3.54.1"},"reference-count":41,"publisher":"The Journal of Rheumatology","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"accepted":{"date-parts":[[2018,6,25]]},"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>To identify clinical features that define disease activity in pediatric localized scleroderma (LS), and determine their specificity and importance.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>We conducted a multicenter prospective study of patients with active and inactive LS skin lesions. A standardized evaluation of a single designated study lesion per subject was performed at 3 visits. We evaluated the pattern and correlation between assessed features and physician\u2019s global assessments of activity (PGA-A).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>Ninety of 103 subjects had evaluable data; 66 had active and 24 inactive disease. Subjects had similar age of onset, sex, and disease patterns. Linear scleroderma was the most common subtype. Features specific for active disease included erythema, violaceous color, tactile warmth, abnormal skin texture, and disease extension. Scores for these variables changed over time and correlated with PGA-A of the lesion. Active and inactive lesions could not be distinguished by the presence or level of skin thickening, either of lesion edge or center. However, in active lesions, skin thickening scores did correlate with PGA\u2013A scores. Regression analysis identified the combination of erythema, disease extension, violaceous color, skin thickening, and abnormal texture as predictive of PGA-A at study entry. Damage features were common irrespective of activity status.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>We identified variables strongly associated with disease activity, expanding upon those used in current measures, and determined their relative importance in physician activity scoring. Skin thickening was found to lack specificity for disease activity. These results will help guide development of a sensitive, responsive activity tool to improve care of patients with LS.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.171381","type":"journal-article","created":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T01:20:04Z","timestamp":1537060804000},"page":"1680-1688","source":"Crossref","is-referenced-by-count":28,"title":["New Features for Measuring Disease Activity in Pediatric Localized Scleroderma"],"prefix":"10.3899","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8276-2866","authenticated-orcid":false,"given":"Suzanne C.","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8278-3878","authenticated-orcid":false,"given":"Xiaohu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2136-5661","authenticated-orcid":false,"given":"Elena","family":"Pope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria C.","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Egla","family":"Rabinovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"O\u2019Neil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen A.","family":"Haines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald M.","family":"Laxer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilynn","family":"Punaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Jacobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9231-1986","authenticated-orcid":false,"given":"Knut","family":"Wittkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2128-0991","authenticated-orcid":false,"given":"Themba","family":"Nyirenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Foeldvari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn S.","family":"Torok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2018,9,15]]},"reference":[{"key":"2025021012250872000_45.12.1680.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.05.045"},{"key":"2025021012250872000_45.12.1680.2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21264"},{"key":"2025021012250872000_45.12.1680.3","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/BOR.0b013e32835896ce","article-title":"Morphea and other localized forms of scleroderma","volume":"24","author":"Vasquez","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"2025021012250872000_45.12.1680.4","first-page":"73","article-title":"The epidemiology of morphea (localized scleroderma) in Olmstead County 1960\u20131993","volume":"24","author":"Peterson","year":"1997","journal-title":"J Rheumatol"},{"key":"2025021012250872000_45.12.1680.5","first-page":"171","article-title":"Localized scleroderma in adults and children. Clinical and laboratory investigations on 239 cases","volume":"13","author":"Marzano","year":"2003","journal-title":"Eur J Dermatol"},{"key":"2025021012250872000_45.12.1680.6","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2010.239"},{"key":"2025021012250872000_45.12.1680.7","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1002\/art.38853","article-title":"Comparison of outcomes in adults with pediatric-onset morphea and those with adult-onset morphea: a cross-sectional study from the morphea in adults and children cohort","volume":"66","author":"Condie","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2025021012250872000_45.12.1680.8","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20407"},{"key":"2025021012250872000_45.12.1680.9","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/bjd.12606","article-title":"Short- and long-term outcome of linear morphoea in children","volume":"169","author":"Piram","year":"2013","journal-title":"Br J Dermatol"},{"issue":"Suppl 10","key":"2025021012250872000_45.12.1680.10","first-page":"S787","article-title":"Description of the localized scleroderma subgroup of the CARRAnet registry","volume":"63","author":"Wu","year":"2011","journal-title":"Arthritis Rheumatol"},{"key":"2025021012250872000_45.12.1680.11","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1980.01640260045011"},{"key":"2025021012250872000_45.12.1680.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2004.10.026"},{"key":"2025021012250872000_45.12.1680.13","doi-asserted-by":"publisher","DOI":"10.1002\/art.30264"},{"key":"2025021012250872000_45.12.1680.14","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/acr.21687","article-title":"Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma","volume":"64","author":"Li","year":"2012","journal-title":"Arthritis Care Res"},{"key":"2025021012250872000_45.12.1680.15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/ddg.12724","article-title":"German guidelines for the diagnosis and therapy of localized scleroderma","volume":"14","author":"Kreuter","year":"2016","journal-title":"J Dtsch Dermatol Ges"},{"key":"2025021012250872000_45.12.1680.16","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090708"},{"key":"2025021012250872000_45.12.1680.17","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1365-2133.2011.10535.x","article-title":"Relapse after systemic treatment in paediatric morphoea","volume":"166","author":"Mirsky","year":"2012","journal-title":"Br J Dermatol"},{"key":"2025021012250872000_45.12.1680.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.03.036"},{"key":"2025021012250872000_45.12.1680.19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07497.x"},{"key":"2025021012250872000_45.12.1680.20","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/bjd.13514","article-title":"Disease recurrence in localized scleroderma: a retrospective analysis of 344 patients with paediatric- or adult-onset disease","volume":"172","author":"Mertens","year":"2015","journal-title":"Br J Dermatol"},{"key":"2025021012250872000_45.12.1680.21","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/bjd.12758","article-title":"Risk factors for morphoea disease severity: a retrospective review of 114 paediatric patients","volume":"170","author":"Pequet","year":"2014","journal-title":"Br J Dermatol"},{"key":"2025021012250872000_45.12.1680.22","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e328309a5eb"},{"key":"2025021012250872000_45.12.1680.23","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.07.2163"},{"key":"2025021012250872000_45.12.1680.24","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/bjd.12255","article-title":"Scanning laser Doppler imaging may predict disease progression of localized scleroderma in children and young adults","volume":"169","author":"Shaw","year":"2013","journal-title":"Br J Dermatol"},{"key":"2025021012250872000_45.12.1680.25","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.jaad.2010.08.027","article-title":"Activity assessment in morphea using color Doppler ultrasound","volume":"65","author":"Wortsman","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"2025021012250872000_45.12.1680.26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08933.x"},{"key":"2025021012250872000_45.12.1680.27","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70079-9"},{"key":"2025021012250872000_45.12.1680.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70077-5"},{"key":"2025021012250872000_45.12.1680.29","first-page":"650","article-title":"Localized scleroderma severity index and global assessments: a pilot study of outcome instruments","volume":"35","author":"Arkachaisri","year":"2008","journal-title":"J Rheumatol"},{"key":"2025021012250872000_45.12.1680.30","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.081284"},{"key":"2025021012250872000_45.12.1680.31","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel446"},{"key":"2025021012250872000_45.12.1680.32","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110210"},{"key":"2025021012250872000_45.12.1680.33","doi-asserted-by":"publisher","DOI":"10.1097\/01.bor.0000245727.40630.c3"},{"key":"2025021012250872000_45.12.1680.34","first-page":"535","article-title":"Sensitivity to change of rheumatoid arthritis clinical trial outcome measures","volume":"20","author":"Anderson","year":"1993","journal-title":"J Rheumatol"},{"key":"2025021012250872000_45.12.1680.35","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780381108"},{"key":"2025021012250872000_45.12.1680.36","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/art.1780210404","article-title":"Collagen in the cellular and fibrotic stages of scleroderma","volume":"21","author":"Fleischmajer","year":"1978","journal-title":"Arthritis Rheum"},{"key":"2025021012250872000_45.12.1680.37","first-page":"1934","article-title":"The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus","volume":"31","author":"Uribe","year":"2004","journal-title":"J Rheumatol"},{"key":"2025021012250872000_45.12.1680.38","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199911)42:11<2365::AID-ANR15>3.0.CO;2-M"},{"key":"2025021012250872000_45.12.1680.39","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/39.2.148"},{"key":"2025021012250872000_45.12.1680.40","doi-asserted-by":"publisher","DOI":"10.1159\/000083509"},{"key":"2025021012250872000_45.12.1680.41","doi-asserted-by":"publisher","DOI":"10.1159\/000250839"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.171381","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T20:26:03Z","timestamp":1739219163000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.171381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,15]]},"references-count":41,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12,1]]},"published-print":{"date-parts":[[2018,12]]}},"alternative-id":["10.3899\/jrheum.171381"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.171381","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,15]]}}}